Medicine & Health

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine researchers.

Antibodies elicited by COVID-19 vaccination become steadily more powerful for at least six months after vaccination, according to a study by researchers at Washington University School of Medicine that involved the Pfizer-BioNTech COVID-19 vaccine.

Medical trailblazer Victoria Fraser, MD, focuses on creating equity in academic medicine.

Health-care workers at the Washington University School of Medicine have contributed greatly to regional and world health during the pandemic, and we owe them so much appreciation.

Researchers at Washington University School of Medicine have shown, in mice, that a new class of compounds they developed can improve several aspects of metabolic syndrome. Such conditions often lead to cardiovascular disease, the leading cause of death worldwide.

Five researchers from the School of Medicine and one from the McKelvey School of Engineering have been named senior members of the National Academy of Inventors.

Washington University School of Medicine is participating in a nationwide phase 2 clinical trial to evaluate whether an investigational omicron-specific booster of the Moderna COVID-19 vaccine is safe and capable of eliciting a strong immune response.

In two recent studies, researchers at Washington University School of Medicine found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

An analysis of federal health data indicates that people who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.

Researchers at Washington University School of Medicine have discovered a molecule in the lungs of tuberculosis (TB) patients that reflects the levels of TB-causing bacteria in the lungs. The findings may represent a step toward more tailored treatment regimens and better patient outcomes.